Globus Medical
GMED
#2015
Rank
$7.38 B
Marketcap
$54.55
Share price
0.17%
Change (1 day)
-6.50%
Change (1 year)

P/E ratio for Globus Medical (GMED)

P/E ratio as of February 2024 (TTM): 26.7

According to Globus Medical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 26.6961. At the end of 2022 the company had a P/E ratio of 39.3.

P/E ratio history for Globus Medical from 2012 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202239.3-19.45%
202148.8-22.21%
202062.768.28%
201937.337.77%
201827.0-26.29%
201736.759.74%
201623.0-2.56%
201523.6-2.8%
201424.3-11.06%
201327.3124.03%
201212.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
51.7 93.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.58-113.41%๐Ÿ‡บ๐Ÿ‡ธ USA
73.6 175.74%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.